eBook | Open R&D: Big Pharma Start Putting Collaboration Plans Into Practice
eBook: Open R&D Big Pharma Start Putting Collaboration Plans Into Practice
There’s no part of the business more in need of metamorphosis than R&D, and no one more convinced of it than pharma’s movers and shakers.
Every major drugmaker has its “transformative” R&D initiative—or two, or a dozen—and they are as varied as the companies they inhabit, from GlaxoSmithKline’s internal pitch-your program sweep-stakes to Pfizer’s aggressive weeding-out to Sanofi’s plethora of academic partnerships. The one thing every effort to pump innovation has in common is this: a desire to make drug development less time-consuming, less expensive and far more effective.
By providing a deep dive on timely industry issues, Fierce eBooks are valuable educational tools. They are designed to be easily read online - but also are formatted so you can print them out and take them with you. Fierce eBooks are assembled like a magazine, read the whole thing cover-to-cover, or pick and choose the articles that interest you most. Either way, they're a great one-stop resource.
Complete the form to the right to download your copy today!
| Wednesday, November 4th | 11:00AM ET / 8:00AM PT | Presented By: Oracle
Attend this webcast for an interactive panel discussion around the findings of a blinded industry survey on eSource in clinical trials – including current and anticipated growth, capabilities critical to eSource, and expected vs. actual benefits. Reserve Your Spot Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!